Skip to main content

Table 3 Fatty acid profiles in red blood cells (RBCs) of controls and CAD patients determined by gas chromatography

From: Correlation of trans fatty acids with the severity of coronary artery disease lesions

 

Controls

n = 120

CAD patients

n = 111

Trans Fatty acids

 C16:1 trans 11

0.42 ± 0.25

0.62 ± 0.34 **

 C18:1 trans 9

0.84 ± 0.37

1.30 ± 0.68**

 C18:1 trans 11

1.63 ± 0.55

1.51 ± 0.55

 C18:2 trans 9 trans 12

0.50 ± 0.35

0.72 ± 0.43**

 C18:2 trans 9 cis 12

0.60 ± 0.50

0.65 ± 0.37*

 C18:2 cis 9 trans 12

0.75 ± 0.46

0.54 ± 0.42**

 C20:1 trans 11

0.51 ± 0.33

0.57 ± 0.32

 C18:2 cis 9 trans 11

0.68 ± 0.40

0.72 ± 0.42

 C18:2 trans 10 cis 12

0.97 ± 0.45

0.95 ± 0.51

Cis Fatty acids

 C16:1 cis 11

0.86 ± 0.43

1.15 ± 6.24**

 C18:1 cis 9

22.09 ± 5.85

22.67 ± 4.74

 C18:1 cis 11

1.73 ± 0.63

1.97 ± 0.58*

 C18:2 cis 9 cis 12

9.98 ± 3.19

7.69 ± 2.30**

 C20:1 cis 11

0.61 ± 0.30

0.62 ± 0.32

 Σ Trans FA

6.91 ± 1.82

7.60 ± 1.92**

 Σ Cis FA

35.29 ± 6.41

34.09 ± 5.33

 Σ SFA

40.66 ± 5.06

43.17 ± 4.03**

 Σ MUFA

32.04 ± 5.83

32.98 ± 4.60

 Σ PUFA

20.55 ± 3.59

17.20 ± 2.53**

 Σ UFA

52.60 ± 5.90

50.18 ± 4.70*

  1. Data are expressed as relative values (%): mean % of total FA ± SD from two independent experiments conducted in triplicate for each CAD patients and controls
  2. Σ Trans FA sum of trans fatty acids, Σ cis FA sum of cis fatty acids
  3. A significant difference between controls and patients is indicated by *(p < 0.05) and **: p < 0.001. The Mann-Whitney test was used
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X